APA (7th ed.) Citation

A, L., C, V. E., M, K., J, P., J, F., L, W., . . . M, P. (2026). Second-line tacrolimus and mycophenolate mofetil in difficult-to-treat autoimmune hepatitis. Hepatology communications, 10(4), . https://doi.org/10.1097/HC9.0000000000000921

Chicago Style (17th ed.) Citation

A, Laschtowitz, et al. "Second-line Tacrolimus and Mycophenolate Mofetil in Difficult-to-treat Autoimmune Hepatitis." Hepatology Communications 10, no. 4 (2026). https://doi.org/10.1097/HC9.0000000000000921.

MLA (9th ed.) Citation

A, Laschtowitz, et al. "Second-line Tacrolimus and Mycophenolate Mofetil in Difficult-to-treat Autoimmune Hepatitis." Hepatology Communications, vol. 10, no. 4, 2026, https://doi.org/10.1097/HC9.0000000000000921.